PGY2 Oncology Pharmacy Residency Program

An Oncology Residency Built to Develop Leaders—Not Just Clinicians

The University of Maryland School of Pharmacy and the University of Maryland Medical Center PGY2 Oncology Pharmacy Residency Program prepares pharmacists to become confident, independent leaders in oncology practice.

ASHP-Accredited PGY2 Oncology Residency
One position per year

The Maryland Difference

Our goal is for residents to leave confident, independent, and ready to lead in oncology pharmacy regardless of the area in which they choose to practice.

Advanced Oncology Practice: Your recommendations aren't simply welcomed—they're expected. Practice at the top of your license within an NCI-designated Comprehensive Cancer Center using an expansive collaborative practice agreement (CPA) to contribute to therapeutic decision making.
Academic Excellence: Graduate as both an exceptional clinician and a confident educator. Teaching, mentorship, and scholarship through the University of Maryland School of Pharmacy are fully embedded opportunities.
Personalized Development: You're known, challenged, and supported. Through close mentorship, progressive autonomy, individualized coaching, and meaningful feedback, residents build confidence and independence throughout the year.
One Integrated Campus: One campus. One team. One learning environment. A seamless connection between patient care, education, and research—less than a five-minute walk between the School of Pharmacy and the Greenebaum Comprehensive Cancer Center.

Program Overview

This program is designed to impart the knowledge and skills necessary for obtaining a position as a clinical pharmacy specialist or clinical faculty member in the area of oncology pharmacy practice.

Through the unique partnership between the University of Maryland School of Pharmacy (UMSOP) and University of Maryland Medical Center that houses the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC), the resident will interface with experts in the field of oncology and palliative care, engage in a diverse array of advanced pharmacy practice experiences, conduct collaborative practice-based research, and mentor student and resident trainees in pharmacy and other health disciplines.

Site and Training Environment

UMMC building exterior at dusk

UMSOP and UMGCCC offer a unique oncology training experience within a National Cancer Institute-designated Comprehensive Cancer Center.

Residents are fully integrated into multidisciplinary teams that combine specialized expertise, clinical research, and extensive support services for patients and their families. This allows residents to manage complex patients while developing in patient care, teaching, research, and leadership through the School of Pharmacy.

As of fall 2026, the Roslyn and Leonard Stoler Center for Advanced Medicine is the new home of the Greenebaum Comprehensive Cancer Center and is built into the University of Maryland Medical Center. The close proximity between the School of Pharmacy and cancer center allows residents to remain deeply engaged in oncology care throughout their training experience.

Explore the Program

What Sets Our Program Apart?
Learn how close mentorship, progressive autonomy, academic integration, and opportunities in research and teaching help residents develop into confident, independent leaders in oncology pharmacy.
Program Curriculum Overview
Explore core and elective rotations, extended and longitudinal practice experiences, and required and optional learning experiences.
Meet the Preceptors
Get to know the pharmacists and faculty who provide clinical training, mentorship, teaching, and support throughout the residency experience.
Application Information
Find the ASHP Program ID and Match number, application deadline, qualifications, application requirements, and program contact information.

Graduate Outcomes

Most Recent Five Graduates

100% Career Placement
Secured oncology pharmacist positions following residency at academic medical centers and comprehensive cancer centers across the country.
80% Board Certification
Are Board Certified Oncology Pharmacists (BCOP) or actively pursuing certification.
80% Research & Scholarship
Have published residency research in peer-reviewed journals, with graduates consistently presenting research and educational programming at national professional meetings.
Teaching & Mentorship
Graduates serve as clinical preceptors for pharmacy students and residents and contribute to the education and development of future pharmacists.
Academic & Professional Leadership
Graduates have assumed faculty appointments, contributed to didactic and experiential education, and actively participate in professional organizations, with many serving in leadership roles.